obot_logo_colour_rgb__1__720_1715793721327.jpg
Ottawa Board of Trade to Unveil Downtown Ottawa Action Agenda
May 17, 2024 08:00 ET | Ottawa Board of Trade
OTTAWA, May 17, 2024 (GLOBE NEWSWIRE) -- The Ottawa Board of Trade (OBOT) alongside the Canadian Urban Institute (CUI), is excited to reveal the release of the Downtown Ottawa Action Agenda –...
Zscaler-Logo-TM-Blue-RGB-20Dec2016.jpg
Zscaler to Present at Upcoming Investor Conference
May 17, 2024 08:00 ET | Zscaler, Inc.
SAN JOSE, Calif., May 17, 2024 (GLOBE NEWSWIRE) -- Zscaler, Inc. (NASDAQ: ZS), the leader in cloud security, today announced that the company is scheduled to present at an upcoming investor...
Appliedlogo_blue_102021 (3).png
Applied Materials to Participate in Upcoming Investor Conferences
May 17, 2024 07:30 ET | Applied Materials, Inc.
SANTA CLARA, Calif., May 17, 2024 (GLOBE NEWSWIRE) -- Applied Materials, Inc. today announced that Gary Dickerson, President and CEO, and Brice Hill, Senior Vice President and CFO, will participate...
Cytokinetics.png
Cytokinetics Hosts Muscle Biology-Focused Research Symposium: Contemporary Landscapes in Muscle Biology
May 17, 2024 07:30 ET | Cytokinetics, Incorporated
SOUTH SAN FRANCISCO, Calif., May 17, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) announced that the Company will host the muscle biology-focused Contemporary Landscapes in...
JOYY to Announce First Quarter 2024 Financial Results on May 28, 2024
May 17, 2024 07:00 ET | JOYY Inc.
SINGAPORE, May 17, 2024 (GLOBE NEWSWIRE) -- JOYY Inc. (NASDAQ: YY) (“JOYY” or the “Company”), a global technology company, today announced that it plans to release its first quarter 2024 financial...
Logo 1-1.png
Chemomab Therapeutics to Participate in Upcoming Scientific Conferences
May 17, 2024 07:00 ET | Chemomab Therapeutics
TEL AVIV, Israel, May 17, 2024 (GLOBE NEWSWIRE) -- Chemomab Therapeutics Ltd. (Nasdaq: CMMB) (Chemomab), a clinical stage biotechnology company developing innovative therapeutics for...
Psyence Biomed logo.png
Psyence Biomed to Participate in the A.G.P. Virtual Healthcare Company Showcase
May 17, 2024 07:00 ET | Psyence Biomedical Ltd.
NEW YORK, May 17, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd (Nasdaq:PBM) (“Psyence Biomed” or the “Company”) today announced that management will host 1x1 meetings with investors during the...
Construmat 2023_034
Construmat grows with the broadest range of sustainable construction solutions
May 17, 2024 04:27 ET | Fira De Barcelona
Construmat 2024, Fira de Barcelona's construction show, increases grows by 50% with over 300 exhibitors and 600 brands.
乐信.png
LexinFintech Holdings Ltd. to Report First Quarter 2024 Unaudited Financial Results on May 23, 2024
May 17, 2024 04:00 ET | LexinFintech Holdings Ltd.
SHENZHEN, China, May 17, 2024 (GLOBE NEWSWIRE) -- LexinFintech Holdings Ltd. (“Lexin” or the “Company”) (NASDAQ: LX), a leading credit technology-empowered consumer financial service enabler in...
HUTCHMED-small-spaced-1000x305-WhiteBgd.png
HUTCHMED Highlights Sovleplenib Phase III ESLIM-01 Study and Hematological Malignancy Programs Data to be Presented at the upcoming EHA2024 Congress
May 16, 2024 20:00 ET | HUTCHMED (China) Limited
HONG KONG, SHANGHAI and FLORHAM PARK, N.J., May 17, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that topline and subgroup results from...